Estimate Recalculated Nov 1, 2024 11:37AM EST
Catherine C. Turkel does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Lexaria Bioscience Corp., and Novus Therapeutics, Inc..
Catherine C. Turkel's CIK is 0001705278
2018 was Catherine C. Turkel's most active year for acquiring shares with 4 total transactions. Catherine C. Turkel's most active month to acquire stocks was the month of February. 2019 was Catherine C. Turkel's most active year for disposing of shares, totalling 2 transactions. Catherine C. Turkel's most active month to dispose stocks was the month of April. 2017 saw Catherine C. Turkel paying a total of $110,998.89 for 113,611 shares, this is the most they've acquired in one year. In 2019 Catherine C. Turkel cashed out on 9,537 shares for a total of $18,611.70, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!